Loading ...

Imatinib in New-onset T1D

(

GleeT1D

)

ITN Protocol #:

ITN825AI

Branded Name:

GleeT1D

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Completed

Summary:

Safety and Efficacy of Imatinib for Preserving B-cell Function in New-onset Type 1 Diabetes Mellitus

Clinical Operations Manager

ITN Biostat

Study Personnel:

Protocol Chair

Stephen Gitelman, MDsgitelma@peds.ucsf.edu

Work: 

415-476-3748

Protocol Chair

Carol Soppecsoppe@immunetolerance.org

Work: 

415-353-4879

Protocol Chair

Noha Lim, PhDnlim@immunetolerance.org

Work: 

240-235-6151